Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by Ghostofrljpon Jan 01, 2020 1:56am

329 Views

Post# 30507830

RE:Still No NR From ONCY

Over 70,000 trades took place on Tues in the US and Canada combined.

That is a few neighbours.

But it is always an issue with chasing the next big thing. They rise and consolidate rise and consolidate. One doesn't need to necessarily rush in.

Time will tell why its rising.

Bullboard Posts

Gold begins to flow at Endeavour's Lafigué mine in Côte d'Ivoire